Coronary Stents Market Regional Analysis, Opportunities And Segmentation With growing CAGR Forecast to 2025
Coronary Stents Market Report provides an overview of latest technologies and in-depth analysis that reflect top vendor’s portfolios and technology
(EMAILWIRE.COM, August 25, 2018 ) The Coronary Stents Market is anticipated to grow at a CAGR of 7.8% and reach US$ 13.88 Bn by 2025
Coronary stents are narrow expandable tubes, which are used to treat coronary diseases such as, artery blockage. These stents are used to perform angioplasty to keep the arteries open in the treatment of coronary artery disease. Coronary stents are usually made up of metal mesh, which acts against corrosion and helps to prevent the artery from recoiling or blocking again.
Download PDF Brochure at http://bit.ly/2MzrQEi
In our study, we have segmented the coronary stents market by type, absorption rate, material and end-users. The coronary stents by type is segmented as biodegradable stents, bare metal stents and drug eluting stents. The absorption rate segment was further segmented as the slow absorption rate and fast absorption rate. The coronary stents market, by material can be categorized as nitinol, polymers, nickel, gold, tantalum, stainless steel and cobalt alloy metal stents.
The end user segment can be segmented into ambulatory surgical centers, hospitals and cardiac centers. Geographically, the market for coronary stents was categorized as North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).
The coronary stents market is subject to strict and mandated regulatory policies. The companies operating in the market follow stringent regulations of the manufacturing guidelines. In addition, these manufacturing companies are focusing to invest in R&D to develop advanced products for end users such as, hospitals, ambulatory surgical centers, and the cardiac centers, among others.
The market for coronary stents is well established in North America region, especially in the U.S and Canada. Rising prevalence of various types of cardiac diseases and subsequent usage of coronary stents to treat these diseases is one of the major factors for the growth of coronary stents market in the country.
According to the American Heart Association (AHA), in 2016, nearly 15.5 million persons aged above 20 years in the US have coronary heart diseases (CHD). The rising number of the coronary heart diseases need more number of coronary stents, hence, the coronary stents market is likely to grow during the forecast period.
Make an Inquiry at http://bit.ly/2Px0c97
The major players operating in the market of coronary stents market include Microport Scientific Corporation, Medtronic PLC, Biosensors International Group, Ltd., Abbott Laboratories, Vascular Concepts Limited, Biotronik SE & Co. Kg, Stentys SA, B. Braun Melsungen AG, Translumina GmbH, and Terumo Corporation.
Coronary stents are narrow expandable tubes, which are used to treat coronary diseases such as, artery blockage. These stents are used to perform angioplasty to keep the arteries open in the treatment of coronary artery disease. Coronary stents are usually made up of metal mesh, which acts against corrosion and helps to prevent the artery from recoiling or blocking again.
Download PDF Brochure at http://bit.ly/2MzrQEi
In our study, we have segmented the coronary stents market by type, absorption rate, material and end-users. The coronary stents by type is segmented as biodegradable stents, bare metal stents and drug eluting stents. The absorption rate segment was further segmented as the slow absorption rate and fast absorption rate. The coronary stents market, by material can be categorized as nitinol, polymers, nickel, gold, tantalum, stainless steel and cobalt alloy metal stents.
The end user segment can be segmented into ambulatory surgical centers, hospitals and cardiac centers. Geographically, the market for coronary stents was categorized as North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).
The coronary stents market is subject to strict and mandated regulatory policies. The companies operating in the market follow stringent regulations of the manufacturing guidelines. In addition, these manufacturing companies are focusing to invest in R&D to develop advanced products for end users such as, hospitals, ambulatory surgical centers, and the cardiac centers, among others.
The market for coronary stents is well established in North America region, especially in the U.S and Canada. Rising prevalence of various types of cardiac diseases and subsequent usage of coronary stents to treat these diseases is one of the major factors for the growth of coronary stents market in the country.
According to the American Heart Association (AHA), in 2016, nearly 15.5 million persons aged above 20 years in the US have coronary heart diseases (CHD). The rising number of the coronary heart diseases need more number of coronary stents, hence, the coronary stents market is likely to grow during the forecast period.
Make an Inquiry at http://bit.ly/2Px0c97
The major players operating in the market of coronary stents market include Microport Scientific Corporation, Medtronic PLC, Biosensors International Group, Ltd., Abbott Laboratories, Vascular Concepts Limited, Biotronik SE & Co. Kg, Stentys SA, B. Braun Melsungen AG, Translumina GmbH, and Terumo Corporation.
Contact Information:
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results